SKYE
Skye Bioscience, Inc. Common Stock
NASDAQ: SKYE · HEALTHCARE · BIOTECHNOLOGY
$0.88
-1.71% today
Updated 2026-04-30
Market cap
$22.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.30
Dividend yield
—
52W range
$1 – $6
Volume
0.6M
Skye Bioscience, Inc. Common Stock (SKYE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-1.27%
ROA
-0.72%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $16243.00 | $4509.00 | 67.03% | 25.35% | 27.76% |
| 2013 | $339926.00 | $-120403.00 | 61.36% | -2.13% | -35.42% |
| 2014 | — | $-2.73M | — | — | — |
| 2015 | — | $-4.84M | — | — | — |
| 2016 | — | $-3.18M | — | — | — |
| 2017 | $0.00 | $-3.09M | — | — | — |
| 2018 | $0.00 | $-19.19M | — | — | — |
| 2019 | $0.00 | $1.05M | — | — | — |
| 2020 | $0.00 | $-6.56M | — | — | — |
| 2021 | $0.00 | $-8.52M | — | — | — |
| 2022 | $0.00 | $-19.48M | — | — | — |
| 2023 | $0.00 | $-37.64M | — | — | — |
| 2024 | $0.00 | $-26.57M | — | — | — |
| 2025 | — | $-55.92M | — | — | — |